Julia Schnoell

The Geriatric Nutritional Risk Index (GNRI) as a Prognostic Biomarker for Immune Checkpoint Inhibitor Response in Recurrent and/or Metastatic Head and Neck Cancer

Markus Haas, Alexander Lein, Thorsten Fuereder et al. · Nutrients · 2023 · 38 citations · Full text

Life Sciences, Nutritional Sciences, Oncology +17

PRKCA Overexpression Is Frequent in Young Oral Tongue Squamous Cell Carcinoma Patients and Is Associated with Poor Prognosis

Thomas Parzefall, Julia Schnoell, Laura Monschein et al. · Cancers · 2021 · 18 citations · Full text

Medicine, Cancer Biology, Oncology +17

Radiosensitizing effect of galunisertib, a TGF-ß receptor I inhibitor, on head and neck squamous cell carcinoma in vitro

Bernhard J. Jank, Teresa Lenz, Markus Haas et al. · Investigational New Drugs · 2022 · 17 citations · Full text

Medicine, Oncology, Radiation Oncology +15

Expression of inhibitors of apoptosis proteins in salivary gland adenoid cystic carcinoma: XIAP is an independent marker of impaired cause‐specific survival

Julia Schnoell, Lorenz Kadletz, Bernhard J. Jank et al. · Clinical Otolaryngology · 2020 · 12 citations · Full text

Medicine, Cancer Biology, Oncology +13

Early on-treatment C-reactive protein and its kinetics predict survival and response in recurrent and/or metastatic head and neck cancer patients receiving first-line pembrolizumab

Markus Haas, Alexander Lein, Thorsten Fuereder et al. · Investigational New Drugs · 2023 · 12 citations · Full text

Medicine, Immunology, Oncology +17